Novo Nordisk PE Ratio 2006-2018 | NVO

Current and historical p/e ratio for Novo Nordisk (NVO) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Novo Nordisk PE ratio as of November 16, 2018 is 17.53.
Novo Nordisk PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-11-16 44.17 17.53
2018-09-30 47.14 $2.52 18.71
2018-06-30 46.12 $2.56 18.02
2018-03-31 49.25 $2.47 19.94
2017-12-31 52.79 $2.32 22.76
2017-09-30 47.36 $2.29 20.68
2017-06-30 41.75 $2.25 18.56
2017-03-31 33.37 $2.26 14.77
2016-12-31 34.22 $2.23 15.34
2016-09-30 39.68 $2.20 18.04
2016-06-30 50.82 $2.11 24.09
2016-03-31 51.21 $1.99 25.73
2015-12-31 53.94 $2.01 26.83
2015-09-30 50.37 $1.92 26.23
2015-06-30 50.85 $1.85 27.49
2015-03-31 49.58 $1.85 26.80
2014-12-31 38.71 $1.73 22.38
2014-09-30 43.56 $1.77 24.61
2014-06-30 42.26 $1.79 23.61
2014-03-31 41.76 $1.76 23.75
2013-12-31 33.18 $1.69 19.58
2013-09-30 30.39 $1.66 18.33
2013-06-30 27.83 $1.58 17.63
2013-03-31 29.00 $1.45 20.00
2012-12-31 28.74 $1.36 21.13
2012-09-30 27.79 $1.27 21.85
2012-06-30 25.59 $1.19 21.54
2012-03-31 24.43 $1.15 21.28
2011-12-31 19.94 $1.11 17.97
2011-09-30 17.22 $1.07 16.15
2011-06-30 21.68 $1.02 21.25
2011-03-31 21.67 $0.95 22.76
2010-12-31 19.20 $0.89 21.47
2010-09-30 16.79 $0.80 21.04
2010-06-30 13.82 $0.75 18.42
2010-03-31 13.15 $0.72 18.32
2009-12-31 10.70 $0.67 15.87
2009-09-30 10.55 $0.65 16.17
2009-06-30 9.12 $0.64 14.17
2009-03-31 8.04 $0.57 14.10
2008-12-31 8.42 $0.55 15.20
2008-09-30 8.39 $0.48 17.48
2008-06-30 10.81 $0.43 24.97
2008-03-31 11.34 $0.33 34.69
2007-12-31 10.49 $0.28 37.34
2007-09-30 9.79 $0.31 31.18
2007-06-30 8.78 $0.28 31.36
2007-03-31 7.32 $0.37 19.79
2006-12-31 6.67 $0.34 19.84
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $107.931B $16.962B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.677B 18.36
Pfizer (PFE) United States $259.009B 14.60
Merck (MRK) United States $205.072B 17.77
Novartis AG (NVS) Switzerland $203.357B 17.38
AbbVie (ABBV) United States $137.681B 12.22
Eli Lilly (LLY) United States $120.583B 21.20
Sanofi (SNY) France $113.115B 14.01
AstraZeneca (AZN) United Kingdom $103.013B 12.79
GlaxoSmithKline (GSK) United Kingdom $100.041B 13.45
Bristol-Myers Squibb (BMY) United States $88.253B 14.53